Literature DB >> 486577

Regulation of plasminogen activator secretion in mouse peritoneal macrophages. I. - Role of serum studied by a new spectrophotometric assay for plasminogen activators.

J C Drapier, J P Tenu, G Lemaire, J F Petit.   

Abstract

A chromogenic tripeptide - H-D-Val-Leu-Lys-p-nitroanilide-substrate of plasmin, can be used to follow plasminogen activation by an activator such as urokinase or the activator secreted by mouse peritoneal macrophages (thioglycolate-elicited). The acceleration of p-nitroaniline production is proportional to the initial rate of plasmin formation from plasminogen. Thus, at a given plasminogen concentration, this acceleration is proportional to the activator concentration. The acceleration can be evaluated from the spectrophotometer trace recording at 405 nm the appearance of p-nitroaniline, either by means of a computer program or by a plot of delta A405 vs.t2. The sensitivity of this assay allows detection of 0.003 CTA units of urokinase. Thioglycollate-elicited mouse peritoneal macrophages secrete plasminogen activator into the extracellular medium during in vitro cultivation only after a contact with serum.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 486577     DOI: 10.1016/s0300-9084(79)80202-3

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  8 in total

1.  The antiangiogenic agent Neovastat (AE-941) stimulates tissue plasminogen activator activity.

Authors:  Denis Gingras; Dominique Labelle; Carine Nyalendo; Dominique Boivin; Michel Demeule; Chantal Barthomeuf; Richard Béliveau
Journal:  Invest New Drugs       Date:  2004-01       Impact factor: 3.850

2.  Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation.

Authors:  L C Petersen; J Brender; E Suenson
Journal:  Biochem J       Date:  1985-01-01       Impact factor: 3.857

3.  Activation of human peripheral blood monocytes by lipoproteins.

Authors:  J L Kelley; M M Rozek; C A Suenram; C J Schwartz
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

4.  Influence of macrophage products on the release of plasminogen activator, collagenase, beta-glucuronidase and prostaglandin E2 by articular chondrocytes.

Authors:  V Evêquoz; J Schnyder; U Trechsel; M Baggiolini; H Fleisch
Journal:  Biochem J       Date:  1984-04-15       Impact factor: 3.857

5.  Modified proenzymes as artificial substrates for proteolytic enzymes: colorimetric assay of bacterial collagenase and matrix metalloproteinase activity using modified pro-urokinase.

Authors:  J H Verheijen; N M Nieuwenbroek; B Beekman; R Hanemaaijer; H W Verspaget; H K Ronday; A H Bakker
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

6.  Inhibition of human factor VIIIa by anti-A2 subunit antibodies.

Authors:  P Lollar; E T Parker; J E Curtis; S L Helgerson; L W Hoyer; M E Scott; D Scandella
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

7.  Release of tissue-type plasminogen activator is induced in rats by leukotrienes C4 and D4, but not by prostaglandins E1, E2 and I2.

Authors:  N Tranquille; J J Emeis
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

8.  Pharmacological modulation of plasminogen activator secretion by P388D1 cell line.

Authors:  G Chow; A Woronick; P Kinkade; R DeLeon; P R Farina; M R Matteo
Journal:  Agents Actions       Date:  1987-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.